Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 237

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 237
---
 segments, primarily through enhanced disclosures about significant segment expenses and segment profit or loss. The ASU also requires entities with a single reportable segment to provide all segment disclosures under ASC 280, including the new required disclosures under the ASU. The ASU is effective for all public entities with fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The ASU must be applied retrospectively. The Company is currently evaluating the impact that ASU 2023-07 will have on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (ASC 740): Improvements to Income Tax Disclosures, which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that ASU 2023-09 will have on its financial statement disclosures.

3. INVENTORY

Inventory consists of the following major classes:

|                 |     |   | September 
       30, 
      2024 |     |   | December 
      31, 
     2023 |
|:----------------|:----|:--|----------:|:----|:--|---------:|
| Work in Process |     | $ |   367,587 |     | $ |  278,987 |
| Finished        
 Goods           |     |   |    84,449 |     |   |  187,182 |
| Inventory       |     | $ |   452,036 |     | $ |  466,169 |

4. PROPERTY AND EQUIPMENT

As of September 30, 2024 and December 31, 2023, Property and Equipment, net consists of:

|                                 |     |   | September 
       30, 
      2024 |   |     |   | December 
      31, 
     2023 |   |
|:--------------------------------|:----|:--|----------:|:--|:----|:--|---------:|:--|
| Lab Equipment                   |     | $ |   233,411 |   |     | $ |  132,911 |   |
| Machinery                       |     |   |